A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy
Clinical trial NCT04023526 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04023526
- Sponsor
- OncoVerity, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2023-08-15
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.